 |
市场调查报告书
商品编码
1394004
北美结构心臟市场预测至 2028 年 - 区域分析 - 按产品、程序和最终用户North America Structural Heart Market Forecast to 2028 - Regional Analysis - by Product, Procedure, and End User |
||||||
北美结构心臟市场预计将从2022年的69.675亿美元成长到2028年的112.0147亿美元。预计2022年至2028年CAGR为8.2%。
创新结构心臟服务的可用性推动北美结构心臟市场
据世界卫生组织（WHO）称，心血管疾病是全球第二大死因。因此，正在采取各种措施来控制心血管疾病。心臟瓣膜疾病预计是心臟衰竭最常见的原因之一。主动脉瓣和二尖瓣的退化性疾病以及三尖瓣功能障碍的疾病在严重的情况下会导致更严重的临床病程。近年来，针对结构性心臟病的微创、外科手术和导管为基础的干预措施急剧增加。结构性心臟是一个不断发展的领域，包括心臟瓣膜手术和经导管手术；因此，正在为心臟外科医生和内科医生安排各种培训方案。在过去的十年中，结构性心臟病的发病率不断上升，因此有必要製定正式的培训计划，以确保劳动力具备适当的能力。不同项目的培训结构、长度和范围差异很大。大多数项目提供经导管主动脉瓣置换术 (TAVR) 手术的扎实暴露，同时提供房间隔或室间隔缺损封堵、左心耳封堵和先天性心臟病干预的较少且可变的经验。随着 TAVR、MitraClip 二尖瓣修復系统（雅培血管）和左心耳封堵术 (LAAO) 手术的出现，用于治疗复杂心血管疾病患者的结构性心臟手术数量显着增加。许多组织已经以有组织的形式为结构性心臟计划开发了服务和程序产品，以适应大量患者的涌入。总体而言，SHD 培训令人兴奋、富有挑战性且回报丰厚。随着该领域的发展，SHD 培训的标准化对于确保患者护理的最佳品质变得极为重要。寻找一位导师来帮助解决概述的众多注意事项可能是成功从培训过渡到实践的最佳资产。
北美结构心臟市场概况
北美结构性心臟市场预计从 2022 年到 2028 年将以 8.2% 的CAGR增长。推动市场成长的关键因素是创新的结构性心臟服务以及心血管疾病和培训项目数量的增加。然而，高昂的手术成本以及有关结构心臟装置的严格法规是阻碍市场成长的主要因素。
北美结构心臟市场收入及 2028 年预测（百万美元）
北美结构心臟市场细分
北美结构心臟市场分为产品、程序、最终用户和国家。
根据产品，北美结构性心臟市场分为封堵器、瓣环成形术环、心臟瓣膜球囊等。 2022 年，封堵器细分市场占据北美结构心臟市场的最大份额。
依手术方式，北美结构性心臟市场分为心臟瓣膜狭窄、心臟瓣膜逆流和左心耳封堵术。 2022 年，心臟瓣膜狭窄细分市场在北美结构性心臟市场中占据最大份额。
根据最终用户，北美结构性心臟市场分为医院、门诊手术中心等。 2022 年，医院细分市场在北美结构性心臟市场中占据最大份额。
根据国家/地区，北美结构心臟市场分为美国、加拿大和墨西哥。 2022年，美国主导北美结构心臟市场。
雅培实验室(Abbott Laboratories)、美敦力公司(Medtronic Plc)、波士顿科学公司(Boston Scientific Corp)、Artivion Inc、Edwards Lifesciences Corp、乐普医疗科技北京有限公司、Braile Biomedica Industry, Commerce and Representations Ltd 和Micro Interventional Devices Inc 是北美结构性医疗行业的一些领先公司。心臟市场。
目录
第 1 章：简介
- 研究范围
- 市场区隔
- 北美结构心臟市场 - 按产品
- 北美结构心臟市场 - 按程序
- 北美结构心臟市场 - 按最终用户划分
- 北美结构心臟市场 - 按国家/地区
第 2 章：北美结构心臟市场 - 要点
第 3 章：研究方法
- 覆盖范围
- 二次研究
- 初步研究
第 4 章：北美结构心臟市场 - 市场格局
- 概述
- PEST分析
- 北美 PEST 分析
- 专家意见
第 5 章：北美结构心臟市场 - 主要市场动态
- 市场驱动因素
- 创新结构性心臟服务的可用性
- 心血管疾病病例和培训计画数量不断增加
- 主要市场限制
- 程序成本高
- 关于结构心臟装置的严格规定
- 主要市场机会
- 人工智慧在结构性心臟的应用越来越广泛
- 未来的趋势
- 结构性心臟器械领域的技术进步
- 影响分析
第 6 章：北美结构心臟市场 - 北美分析
- 北美结构心臟市场收入预测与分析
第 7 章：北美结构心臟市场 - 收入和 2028 年预测 - 按产品
- 概述
- 北美结构心臟市场收入份额，按产品 2021 年和 2028 年 (%)
- 封堵器
- 瓣环成形术环
- 心臟瓣膜气球
- 其他的
第 8 章：北美结构心臟市场 - 2028 年收入和预测 - 按程序
- 概述
- 北美结构心臟市场收入份额，按程序 2021 年和 2028 年 (%)
- 心臟瓣膜狭窄
- 心臟瓣膜逆流
- 左心耳封堵术
第 9 章：北美结构心臟市场 - 收入和 2028 年预测 - 按最终用户
- 概述
- 2021 年和 2028 年北美结构心臟市场收入份额（按最终用户划分）（%）
- 医院
- 门诊手术中心
- 心臟中心
第 10 章：北美结构心臟市场 - 2028 年收入与预测 - 国家分析
- 北美：北美结构心臟市场
- 概述
第 11 章：北美结构心臟市场 - 产业格局
- 概述
- 成长策略
- 概述
第 12 章：公司简介
- Abbott Laboratories
- Medtronic Plc
- Boston Scientific Corp
- Artivion Inc
- Edwards Lifesciences Corp
- Lepu Medical Technology Beijing Co Ltd
- Braile Biomedica Industry, Commerce and Representations Ltd
- Micro Interventional Devices Inc
第 13 章：附录
- 关于洞察合作伙伴
- 专业术语
The North America structural heart market is expected to grow from US$ 6,967.50 million in 2022 to US$ 11,201.47 million by 2028. It is estimated to grow at a CAGR of 8.2% from 2022 to 2028.
Availability of Innovative Structural Heart Services Fuel North America Structural Heart Market
According to the World Health Organization (WHO), cardiovascular diseases are the second leading cause of death worldwide. Therefore, various initiatives are being taken to control cardiovascular diseases. Heart valve disease is expected to be one of the most common causes of heart failure. Degenerative diseases of aortic and mitral valves, and diseases of dysfunctional tricuspid valves lead to a worse clinical course in severe cases. Minimally invasive, surgical, and catheter-based interventions for structural heart disease have increased dramatically recently. The structural heart is an evolving field consisting of heart valve surgeries and transcatheter procedures; therefore, various training programs are being arranged for cardiac surgeons and physicians. Over the past decade, the burgeoning incidence of structural heart disease has necessitated the development of formal training programs to ensure the appropriate competency of workforces. The structure, length, and scope of training vary greatly between programs. Most programs provide solid exposure on transcatheter aortic valve replacement (TAVR) procedures, simultaneously providing a lesser and variable experience of atrial septal or ventricular septal defect closure, left atrial appendage closure, and congenital heart defect interventions. With the advent of TAVR, the MitraClip mitral valve repair system (Abbott Vascular), and left atrial appendage occlusion (LAAO) procedures, there has been a significant increase in the volume of structural cardiac procedures performed for treating patients with complex cardiovascular conditions. Many organizations have developed services and procedural offerings in an organized format for the structural cardiac program to accommodate the influx of patients. Training in SHD is exciting, challenging, and rewarding overall. As the field evolves, standardization of SHD training becomes extremely important to ensure the best quality of patient care. Finding a mentor to help navigate the numerous considerations outlined can be the best asset to successfully transitioning from training to practice.
North America Structural Heart Market Overview
The North America Structural heart market is estimated to grow at a CAGR of 8.2% from 2022 to 2028. Key factors driving the market growth are innovative structural heart services and rise in the number of cardiovascular diseases and training programs. However, high cost of procedure followed by stringent regulations regarding structure heart device are the major factor hampering the growth of the market.
North America Structural Heart Market Revenue and Forecast to 2028 (US$ Million)
North America Structural Heart Market Segmentation
The North America structural heart market is segmented into product, procedure, end user, and country.
Based on product, the North America structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the North America structural heart market in 2022.
Based on procedure, the North America structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the North America structural heart market in 2022.
Based on end user, the North America structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the North America structural heart market in 2022.
Based on country, the North America structural heart market is segmented into US, Canada, and Mexico. US dominated the North America structural heart market in 2022.
Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, Lepu Medical Technology Beijing Co Ltd, Braile Biomedica Industry, Commerce and Representations Ltd, and Micro Interventional Devices Inc are some of the leading companies operating in the North America structural heart market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America structural heart market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in North America structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.2.1 North America Structural Heart Market - by Product
- 1.2.2 North America Structural Heart Market - by Procedure
- 1.2.3 North America Structural Heart Market - by End User
- 1.2.4 North America Structural Heart Market - by Country
2. North America Structural Heart Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Structural Heart Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.3 Expert's Opinion
5. North America Structural Heart Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Availability of Innovative Structural Heart Services
- 5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
- 5.2 Key Market Restraints
- 5.2.1 High Cost of Procedures
- 5.2.2 Stringent Regulations Regarding Structure Heart Devices
- 5.3 Key Market Opportunities
- 5.3.1 Growing Use of Artificial Intelligence in Structural Heart
- 5.4 Future Trends
- 5.4.1 Technological Advancements in the Field of Structural Heart Devices
- 5.5 Impact analysis
6. North America Structural Heart Market -North America Analysis
- 6.1 North America Structural Heart Market Revenue Forecast and Analysis
7. North America Structural Heart Market - Revenue and Forecast to 2028 - by Product
- 7.1 Overview
- 7.2 North America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
- 7.3 Occluders
- 7.3.1 Overview
- 7.3.2 Occluders: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Annuloplasty Rings
- 7.4.1 Overview
- 7.4.2 Annuloplasty Rings: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Heart Valve Balloons
- 7.5.1 Overview
- 7.5.2 Heart Valve Balloons: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Structural Heart Market - Revenue and Forecast to 2028 - by Procedure
- 8.1 Overview
- 8.2 North America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
- 8.3 Heart Valve Stenosis
- 8.3.1 Overview
- 8.3.2 Heart Valve Stenosis: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Heart Valve Regurgitation
- 8.4.1 Overview
- 8.4.2 Heart Valve Regurgitation: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Left Atrial Appendage Closure
- 8.5.1 Overview
- 8.5.2 Left Atrial Appendage Closure: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Structural Heart Market - Revenue and Forecast to 2028 - by End User
- 9.1 Overview
- 9.2 North America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
- 9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Cardiac Centers
- 9.5.1 Overview
- 9.5.2 Cardiac Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Structural Heart Market - Revenue and Forecast to 2028 -Country Analysis
- 10.1 North America: North America Structural Heart Market
- 10.1.1 Overview
- 10.1.1.1 United States: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 Overview
- 10.1.1.1.2 United States: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.3 United States: North America Structural Heart Market , by Product, 2019-2028 (US$ Million)
- 10.1.1.1.4 United States: North America Structural Heart Market , by Procedure, 2019-2028 (US$ Million)
- 10.1.1.1.5 United States: North America Structural Heart Market , by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
- 10.1.1.1.6 United States: North America Structural Heart Market , by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
- 10.1.1.1.7 United States: North America Structural Heart Market , by End User, 2019-2028 (US$ Million)
- 10.1.1.2 Canada: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Overview
- 10.1.1.2.2 Canada: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.3 Canada: North America Structural Heart Market , by Product, 2019-2028 (US$ Million)
- 10.1.1.2.4 Canada: North America Structural Heart Market , by Procedure, 2019-2028 (US$ Million)
- 10.1.1.2.5 Canada: North America Structural Heart Market , by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
- 10.1.1.2.6 Canada: North America Structural Heart Market , by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
- 10.1.1.2.7 Canada: North America Structural Heart Market , by End User, 2019-2028 (US$ Million)
- 10.1.1.3 Mexico: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Overview
- 10.1.1.3.2 Mexico: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.3 Mexico: North America Structural Heart Market , by Product, 2019-2028 (US$ Million)
- 10.1.1.3.4 Mexico: North America Structural Heart Market , by Procedure, 2019-2028 (US$ Million)
- 10.1.1.3.5 Mexico: North America Structural Heart Market , by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
- 10.1.1.3.6 Mexico: North America Structural Heart Market , by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
- 10.1.1.3.7 Mexico: North America Structural Heart Market , by End User, 2019-2028 (US$ Million)
- 10.1.1.1 United States: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1 Overview
11. North America Structural Heart Market -Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies
- 11.2.1 Overview
12. Company Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Medtronic Plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Boston Scientific Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Artivion Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Edwards Lifesciences Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Lepu Medical Technology Beijing Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Braile Biomedica Industry, Commerce and Representations Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Micro Interventional Devices Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
- 13.1 About the Insight Partners
- 13.2 Glossary of Terms
List Of Tables
- Table 1. Structural Heart Training Programs in the US
- Table 2. United States North America Structural Heart Market , by Product - Revenue and Forecast to 2028 (US$ Million)
- Table 3. United States North America Structural Heart Market , by Procedure - Revenue and Forecast to 2028 (US$ Million)
- Table 4. United States North America Structural Heart Market , by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
- Table 5. United States North America Structural Heart Market , by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
- Table 6. United States North America Structural Heart Market , by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 7. Canada North America Structural Heart Market , by Product - Revenue and Forecast to 2028 (US$ Million)
- Table 8. Canada North America Structural Heart Market , by Procedure - Revenue and Forecast to 2028 (US$ Million)
- Table 9. Canada North America Structural Heart Market , by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
- Table 10. Canada North America Structural Heart Market , by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
- Table 11. Canada North America Structural Heart Market , by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 12. Mexico North America Structural Heart Market , by Product - Revenue and Forecast to 2028 (US$ Million)
- Table 13. Mexico North America Structural Heart Market , by Procedure - Revenue and Forecast to 2028 (US$ Million)
- Table 14. Mexico North America Structural Heart Market , by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
- Table 15. Mexico North America Structural Heart Market , by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
- Table 16. Mexico North America Structural Heart Market , by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 17. Recent Organic Growth Strategies in North America Structural Heart Market
- Table 18. Glossary of Terms
List Of Figures
- Figure 1. North America Structural Heart Market Segmentation
- Figure 2. North America Structural Heart Market , by Country
- Figure 3. North America Structural Heart Market Overview
- Figure 4. Occluders Segment Held Largest Share of Product Segment in North America Structural Heart Market
- Figure 5. North America: PEST Analysis
- Figure 6. North America Experts' Opinion
- Figure 7. North America Structural Heart Market : Impact Analysis of Drivers and Restraints
- Figure 8. North America Structural Heart Market - Revenue Forecast and Analysis - 2019-2028
- Figure 9. North America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
- Figure 10. Occluders: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 11. Annuloplasty Rings: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 12. Heart Valve Balloons: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Others: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 14. North America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
- Figure 15. Heart Valve Stenosis: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 16. Heart Valve Regurgitation: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 17. Left Atrial Appendage Closure: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 18. North America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
- Figure 19. Hospitals: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Ambulatory Surgical Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 21. Cardiac Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 22. North America: North America Structural Heart Market , by Key Country - Revenue (2021) (US$ Million)
- Figure 23. North America: North America Structural Heart Market , by Country, 2021 & 2028 (%)
- Figure 24. United States: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 25. Canada: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 26. Mexico: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
